- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00890071
Brachial Artery Peak Velocity Variation to Predict Fluid Responsiveness
Brachial Artery Peak Velocity Variation to Predict Fluid Responsiveness in Mechanically Ventilated Patients
Study Overview
Detailed Description
Predicting the hemodynamic response to fluid administration (or fluid responsiveness) in critical ill patients is still a matter of concern, since fluid overload could worse the clinical situation of these patients. Parameters of fluid responsiveness usually require an invasive monitoring (like arterial pulse pressure variation).
We hypothesize that noninvasive evaluation of respiratory variation of peak velocity in brachial artery using Doppler ultrasound could provide a feasible estimation on fluid responsiveness in mechanically ventilated patients with acute circulatory failure.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Cádiz
-
Jerez de la Frontera, Cádiz, Spain, 11407
- Hospital del SAS de Jerez
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients with controlled mechanical ventilation, equipped with an indwelling radial artery catheter and for whom the decision to give fluids will be taken because the presence of one or more clinical signs of acute circulatory failure:
- systolic blood pressure <90 mmHg (or a decrease >50 mmHg in previously hypertensive patients)
- the need of vasopressor drugs
- oliguria (urine output <0.5 ml/kg/min for at least 2 h)
- tachycardia
- delayed capillary refilling
- the presence of skin mottling
Exclusion Criteria:
- Contraindication for the volume administration: evidence of fluid overload and/or of hydrostatic pulmonary edema
- Patients with instable cardiac rhythm
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Acute circulatory failure
Patients for whom the decision to give fluids was taken because the presence of one or more clinical signs of acute circulatory failure.
|
500 ml of synthetic colloid (Voluven®, hydroxyethylstarch 6%; Fresenius, Bad Homburg, Germany) infused over 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Predictive value of respiratory variation in brachial artery peak velocity before volume expansion assessed by ROC curve. We defined responser as patients that increased stroke volume index equal or more than 15% after fluid administration.
Time Frame: immediately after volume expansion
|
immediately after volume expansion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluate the predictive value of pulse pressure variation for predicting hemodynamic response to fluid administration, comparing with the predictive value of respiratory variation of brachial artery peak velocity.
Time Frame: immediately after fluid administration
|
immediately after fluid administration
|
Evaluate the predictive value of stroke volume variation for predicting hemodynamic response to fluid administration, comparing with the predictive value of respiratory variation of brachial artery peak velocity.
Time Frame: immediately after volume expansion
|
immediately after volume expansion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: M. Ignacio Monge García, Hospital del SAS de Jerez
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UIE-SCCU-200902
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsRecruitingWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedSepsis | Toxic-Shock Syndrome
-
King's College Hospital NHS TrustUniversity Hospital BirminghamCompletedTraumatic Haemorrhagic ShockUnited Kingdom
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
National Institute of Allergy and Infectious Diseases...Completed
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
-
Ramathibodi HospitalUnknownSeptic Shock | Refractory ShockThailand
-
Assiut UniversityUnknown
Clinical Trials on Fluid administration
-
Karolinska University HospitalUnknown
-
University Hospital Hradec KraloveUniversity Hospital PilsenCompletedSepsis | Septic Shock | Surgery | Endothelial Dysfunction | AnesthesiaCzechia
-
University College, LondonUnknownHypovolemia | Dehydration (Physiology) | Thirst; Due to Deprivation of Water | Plasma Osmolality IncreasedUnited Kingdom
-
University of Southern CaliforniaCompleted
-
St George's Healthcare NHS TrustUnknownPeri-operative Fluid Management
-
University of ManitobaCompleted
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Rigshospitalet, DenmarkSnedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation; Danish... and other collaboratorsCompletedCardiac Magnetic Resonance | Healthy Individuals | T1 MappingDenmark
-
Tel-Aviv Sourasky Medical CenterUnknownSepsis | Acute Lung Injury (ALI) | Acure Respiratory Distress Syndrome (ARDS)Israel
-
Seoul National University HospitalCompletedComparison of Two Different Preload Targets of Stroke Volume Variation During Kidney TransplantationRenal Failure Chronic | Kidney Transplant; ComplicationsKorea, Republic of